Concepedia

Praveen K. Bommareddy

PK

Statistics

Publications

24

Citations

1.3K

H-Index

18

Active since

2015

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Massachusetts General Hospital

Rush University Medical Center

Harvard University

Praveen K. Bommareddy is an author at Rutgers, The State University of New Jersey specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2015–2025

24

Publications

24

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Jenna H. Newman, Charles B. Chesson, Nora L. Herzog et al. · Proceedings of the National Academy of Sciences · 2019 · 185 citations · Full text

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

Suzanne Thomas, Linta Kuncheria, Victoria Roulstone et al. · Journal for ImmunoTherapy of Cancer · 2019 · 156 citations · Full text

MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation

Praveen K. Bommareddy, Salvatore Aspromonte, Andrew Zloza et al. · Science Translational Medicine · 2018 · 126 citations · Full text

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma

Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin et al. · OncoImmunology · 2019 · 119 citations · Full text

Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response

Laura Poillet-Perez, Daniel W. Sharp, Yang Yang et al. · Nature Cancer · 2020 · 108 citations · Full text

, , +13

1–5 of 24